A National Survey on Congenital Hypothyroidism Newborn Screening in Pakistan

Sabeen Abid Khan1, Sommayya Aftab2, Yasir Naqi Khan3

  • 1Shifa college of Medicine, Shifa Tameer-e-Millat University, Islamabad, Pakistan.

Global Pediatric Health
|November 11, 2024
PubMed

Insights

Newborn screening for congenital hypothyroidism (CH) is widely believed essential in Pakistan, yet current screening practices show significant variation. Cost and lack of services hinder widespread implementation of CH screening.

Area of Science:

  • Pediatrics
  • Endocrinology
  • Public Health

Background:

  • Congenital hypothyroidism (CH) is a treatable condition requiring prompt diagnosis for optimal outcomes.
  • Neonatal screening programs for CH are not routinely established in developing nations like Pakistan.
  • Early detection through screening is crucial to prevent developmental issues associated with CH.

Purpose of the Study:

  • To investigate current newborn screening practices for congenital hypothyroidism in Pakistan.
  • To identify barriers and variations in the implementation of CH screening programs nationwide.

Main Methods:

  • An online survey was conducted using Google Forms.
  • The survey targeted national pediatric societies and hospitals across Pakistan.
  • Data from 341 respondents, primarily pediatricians, were analyzed.

Main Results:

  • Over 90% of respondents deemed newborn screening for CH essential.
  • However, only 41.3% of respondents reported offering CH screening in practice.
  • Key barriers included the cost of testing (32.2%), unavailability of services (8.5%), and lack of policies (5.8%).

Conclusions:

  • Significant disparities exist in congenital hypothyroidism newborn screening practices across Pakistan.
  • Addressing cost, service availability, and policy development is critical to improve CH screening rates.

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...